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O ives
. This study was designed to reassess the prediction
of recurrent nonfatal myocardial infarction in patients recovering
from acute
myocardial Infarction after thrombolysis .
llnc d. Recurrent nonfatal myocardial infarction
is a
strong
and independent predictor of subsequent mortality . Cur-
rent knowledge of risk factors for nonfatal reinfarction is still
largely based on data
thered before the advent of thrombolysis .
Thus, this prospective study was planned to identify harbingers of
nonfatal reinfarction in the postinfarction patients of the multi-
center Gruppo Italiano per to
Studio delta Sopravvivenza
nell'Infarto Mioeardico (GISSI-2) trial .
Methods. Predictors of nonfatal reinfarction at 6 months were
analyzed by multivariate technique (Cox model) in 8,907 GISSI-2
survivors of myocardi:_' infarction with clinical follow-up, relying
on a set of prespecified variables reflecting residual ischemia, left
ventricular failure or dysfunction, complex ventricular arrhyth-
miss, comorbidity as well as demographic and historical
factors
.
Results . The postdiseharge to 6- month incidence rate of non-
fatal reinfarction was 2.5%.
Independent predictors of nonfatal
Nonfatal reinfarction after an index acute myocardial
infarc-
tion is a strong independent predictor of subsequent mortality
(1-3).
Thus, continuing investigation of risk factors for recur-
rent nonfatal myocardial infarction appears important for the
improvement of management policies in survivors of myocar-
dial infarction. Most studies examining the prognostic factors
for nonfatal reinfarction (1,4-8) were carried out before the
widespread application of thrombolysis . Therefore
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reinfarction were cardiac ineligibility for exercise test (relative
risk 2.97,95% confidence interval ICII 1.98 to 4 .45), previous
myocardial infarction (relative risk 1 .70,95% CI 1 .22 to 2.36) and
angina at follow-up (relative risk 1.50,95% Cl 1 .10 to 2 .04). On
further multivariate analysis, performed in 6,580 patients with
both echocardiographic and electrocardiographic monitoring
data available, a history of angina emerged as an additional risk
predictor (relative risk 1 .58, 95% Cl 1 .10 to 2 .25).
Conclusions. The 6-month incidence of nonfatal reinfarction is
rather low in survivors of myocardial infarction after thromboly-
sis . Cardiac ineligibility for exercise testing and a history of
coronary artery disease are risk predictors . Recurren 4 nonfatal
infarction is not predictable by qualitative variables reflecting
residual ischemia, except by postdischarge angina . Prediction of
nonfatal reinfarction appears less accurate than prediction of
mortality, as almost 50% of reinfarctions occur in patients without
any of the identi)"a~d risk factors.
U Am Coll Cordiol 1994:24:608-15)
framework of the large GISSI-2 data base (9), a specific study
was planned to reassess the prediction of nonfatal reinfarction
in patients recovering from acute myocardial infarction after
thrombolysis. This report describes the results of the prospec-
tive analysis of the risk factors for recurrent nonfatal myocar-
dial infarction in the postinfarction patients of the multicenter
GISSI-2 trial (10,11).
Methods
Study patients. The 8,907 hospital survivors considered in
this report had been enrolled in the GISSI-2 study, a factorial,
randomized open trial designed to compare the benefits and
risks of two thrombolytic agents, streptokinase and alteplase,
in patients with acute myocardial infarction . The patients were
also randomized to receive subcutaneous heparin or usual
therapy. Exclusion criteria, the method of randomization,
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procedures for the administration of trial medications as well
as guidelines for the recommended treatments have been
reported elsewhere (10) .
Patients were eligible for enrollment in the GISSI-2 study
1) if they had chest pain accompanied by ST segment elevation
0 1 mm in any limb lead of the electrocardiogram (ECG) or
~2 mm in any precordial lead, or both; 2) if they had been
admitted to the coronary care unit within 6 h of the onset of
symptoms; and 3) if they had no clear contraindication to the
fibrinolytic treatments or to heparin .
The patients included in this data base study were those in
whom a diagnosis of definite acute myocardial infarction was
validated at a central coordinating center on the basis of two of
the following three criteria : 1) prolonged Willie chest pain ;
2) new appearance of abnormal Q waves with evolutionary ST
and T wave changes on serial tracings; 3) enzymatic evidence,
as indicated by an elevation of total serum creatine kinase to
twice the upper limit of normal values .
Data collection. Before randomization a set of demo-
graphic and historical variables was collected prospectively fir
each patient . In addition, individual information on the clinical
course, major clinical events, other treatments during hospital
admission and at discharge and laboratory examinations was
collected on a single forni . Data on postdischarge clinical
events, cardiovascular medications and revascularization pro-
cedures were reported on a follow-up form . These firms,
together with three ECGs taken at set intervals (at entry, after
4 h and at hospital discharge) were sent to the coordinating
center for review of the completeness and consistency of data
and for central computer analysis of the ECG . The ECGs
oatained in patients with early spontarcous postinfarction
angina or reinfarction were also reviewed in the coordinating
center.
Electrocardiography and special tests. Standard 12-lead
ECGs were read centrally by four cardiologists and categorized
according to the site and type of infarct . For the purpose of this
study, infarct site was classified as inferior in the presence of
either or both 1) pathologic 0 waves in leads II, 111 and aVF
or 2) an R/S wave ratio jl in leads V 1 and V 2. The broad
category of anterior infarct site included anterior location
(pathologic Q waves in leads V1 to V4), lateral location
(pathologic 0 waves in isolated leads I and aVL or isolated
leads
V5
and VJ and anteroinferior location (concomitant
signs of anterior and inferior infarction without a history of
previous infarction). The development of new Q waves, 0.03 s
in duration, was taken as evidence of a Q wave infarction, and
the presence of serial ST-T wave changes in the absence of new
Q waves in the predischarge ECG was judged to indicate a
non-Q wave infarction. Patients with R/S ~ I in leads V , to V2
were assigned to the Q wave group.
Two-dimensional echocardiography was performed to as-
sess segmental left ventricular systolic function just before the
patients were discharged from the hospital (-2 weeks after the
onset of infarction) . Ejection fraction was calculated from left
ventricular two-dimensional tomograms by either the area-
length method or modified Simpson's rule (12). The segmental
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left ventricular performance pattern was evaluated to generate
an infarct size index expressed as the percent of akinetic or
dyskinctic segments. This functional index indirectly reflects
left ventricular function as it is dependent on the degree of
overall myocardial damage caused by ischemia or infarction .
For wall motion analysis from standard two-dimensional to-
mograms (parasternal, apical and subcostal views), the left
ventricular wall was divided into I I segments according to the
model originally proposed by Edwards et al . (13) as modified
to consider the apex as a single segment (14) .
An echocardiographic examination was not available for
17.8% of the patients, mostly because of poor echogenicity or
logistic reasons. A determination of election fraction was
available in 28 .4% of the patients . A symptom-limited exercise
stress test was performed, whenever possible, within 30 days
from randomization according to standards and guidelines for
exercise testing provided by an Italian ad hoc committee (15) .
Approximately 36% of patients were excluded from stress
testing on clinical grounds . In 85% of the patients, 24-h 1-Cotter
ambulatory ECG monitoring was performed shortly before
hospital discharge: the other 15% did not have a Flolter
recording for logistic or technical reasons . Premature ventric-
ular complexes were categorized according to mean frequency
per hour and presence of repetitive forms (couplets, runs or
ventricular tachycardia) .
Quality control. Quality control of special tests (i .e ., 24-h
Holier ECG recordings, exercise stress ECGs and tape record-
ings of echocardiographic examinations) was ensured at the
coordinating center by random check of a selected sample of
--10/0 of all examinations performed by each laboratory . All
checking was performed by a staff of experienced cardiologists
who had no knowledge of study treatments . Quality control
was meant to verify the correct assignment of patients accord-
ing to the presence or absence of prcspecificd risk variables .
The highly satisfactory resufts of this quality control have been
reported elsewhere ((9) .
Risk variables . For the purpose of this data bank study, an
ad hoc committee developed written, a priori hypotheses
concerning risk factors for recurrent nonfatal myocardial in-
farction, relying on review of published studies and consensus
among the members of the committee . The variables analyzed
includedd data from the history, ECG, hospital and postdis-
charge course and special tests. The following historical and
demographic variables were selected : advanced age (>70
years), female gender, history of angina (>1 month in duration
before the index infarction), history of previous myocardial
infarction, history of treated hypertension, insulin-dependent
diabetes mellitus and history of cigarette smoking .
Some variables related to the hospital course. Early left
ventricular failure was defined as Fillip class >11 on admission
or the new appearance of symptoms and signs
of left ventric-
ular failure within day 4 after entry into the coronary care unit .
Late left ventricular failure
was defined as the first appearance
or persistence of symptoms and signs of left ventricular failure
after day 4 of the hospital stay
. For the diagnosis of left
ventricular failure at least two of the following signs or
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symptoms were required: 1) bibasilar pulmonary rates, 2) a
third heart sound, 3) dyspnea, 4) radiographic evidence of
pulmonary congestion . Early spontaneous postinfarction angina
was defined as the occurrence of typical ischemic chest pain
manifesting at rest or on minimal exercise during the hospital
stay X24 h after randomization; transient ST segment depres-
sion or elevation >-1 mm, or inversion or pseudonormalization
of the T wave during the episode of chest pain was also
required for this diagnosis.
The occurrence of angina pectoris after hospital discharge
was recorded on the 6-month follow-up data form, and epi-
sodes were classified as effort, spontaneous or mixed angina .
The first notation of angina at follow-up (antedating the
prognostic end point) was analyzed in the present study.
From special tests the following variables were generated .
Recovery
phase
left ventricular dysfunction was defined as an
echocardiographic left ventricular ejection fraction <0 .40 or,
whenever an ejection fraction determination was not available,
the presence of >36% akinetic or dyskinetic myocardial seg-
ments; the latter indicator of left ventricular dysfunction was
selected assuming that its adverse impact on survival was
roughly similar to that of an ejection fraction <0.40 (9). The
presence of complex ventricular an*ythmias during 24-h ECG
monitoring was defined as frequent (2!10th) premature ven-
tricular beats or couplets, or both, runs or ventricular tachy-
cardia. The development of angina during exercise or the
appearance of ST segment depression >1 mm 0.08 s after the
J point, as determined by the clinic physician, was taken as
evidence of a positive exercise test (i
.e.,
effort residual ischemia) .
Exclusion from exercise stress
testing for both cardiac and
noncardiac clinical reasons was selected as an additional
exercise test-related variable in view of previous studies (16)
that consistently showed the process of being excluded for
clinical reasons from exercise testing to identify a high risk
group of postinfarction patients . Inferior site of infarct was the
only candidate variable derived from the ECG . Type of
infarction (non-Q wave vs. Q wave) was excluded from this
analysis because the subset of patients with a non-Q wave
infarct included in this data base (i .e ., those presenting with ST
segment elevation) did not have an excess of nonfatal reinfarc-
tion in comparison with that of the 0 wave group at prelimi-
nary screening of relevant risk determinants (the incidence
rate of nonfatal reinfarction was, respectively, 2 .6% vs . 2.5%).
Folow-up. The participating clinical centers were asked to
monitor their patients after hospital discharge for clinically
relevant events occurring in the 1st 6 months from admission
to the trial. Recurrent myocardial infarction was defined
according to the same criteria as the index infarction ; this
diagnosis had to be validated at the coordinating center. The
prespecified end point of this study-recurrent nonfatal myo-
cardial infarction-was defined as survival of reinfarction by 30
days. Patients with a first reinfarction during follow-up were
considered to have reached an end point and, among them,
subsequent reinfarctions were not analyzed .
Stadsdeal analysis . All patients were included in the study
regardless of missing data. Those for whom information con-
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cerning one of the candidate variables was missing were
grouped in a separate category. Accordingly, for every factor a
dummy variable was created whose value was 1 for missing
information and 0 otherwise. The association of each variable
with nonfatal reinfarction was assessed first by calculating the
crude odds ratio and the 95% confidence intervals. All vari-
ables were then included in a Cox regression model (17)
(Statistical Analysis System 6.07, PHREG procedure; SAS
Institute Inc.) to control simultaneously for potential con-
founding factors. A model including the same variables, but
restricted to the 6,580 patients for whom both the echocardio-
graphic indicator and 24-h Holter monitoring data were avail-
able, was then fitted to better control the role of these variables
as a confounding factor. The 183 patients (2.1%) who died
during the study period and did not experience a nonfatal
reinfarction were considered censored at the time of death .
Likewise, additional univariate and multivariate analyses were
performed to evaluate the importance of selected variables for
the prognostic end point, any recurrent (nonfatal plus clinically
reported fatal) infarction.
Results
Altogether, 10,407 patients were discharged from the hos-
pital with a diagnosis of definite acute myocardial infarction
(Fig. 1) . Follow-up information concerning reinfarction status
was unavailable for 1,500 patients (14 .4%) . Of these patients,
188 had been lost to follow-up . Among 1,170 hospital survivors
without clinical follow-up, and thus analyzed by coordinating
center with regard to their vital status, a 6-month death rate of
5.9% was observed. For 142 additional patients, traced by
clinical centers, reinfarction status could not be ascertained
mostly because of early sudden deaths (107 events) . Overall,
patients without information on reinfarction status exhibited a
higher mortality risk than those making up the study group .
The baseline characteristics of the 8,907 patients included in
this analysis are reported in Table 1 .
Recurrent Infarction . Among the 8,907 hospital survivors
with complete follow-up data (85 .6% of the total) a first
recurrence was observed in 260 patients by 6 months (a 2 .9%
rate). In 38 patients a fatal outcome was observed within 30
days of the new infarction (fatal reinfarctions). Of these
patients, 32 (84%) died within 1 week of the reinfarction .
Overall, 222 patients experienced a nonfatal reinfarction by 6
months (a 2.5% rate). This 2.5% rate appears lower than that
found in the corresponding GISSI-1 cohort allocated to strep-
tokinase therapy (2 .9%, p = NS) but higher than that observed
in the similar cohort assigned to usual treatment (1 .9%, p <
0.05). Notably, the two patient groups had a comparable
prevalence of a history of previous infarction (13 .7% for
GISSI-2 patients and 14.7% for GISSI-1 patients) .
Time course of nonfatal reinfarction . Excluding the 1st 30
days after hospital discharge in which a peak of incidence
(nearly 33% of all recurrences) was seen, nonfatal reinfarc-
tions occurred at a rather stable rate during follow-up .
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Figure 1 . GISSI-2 data base flowchart . AMI =
acute myocardial infarction
; nonfatal reinfarc(ions
= survival for >30 days after new infarction occur-
ring c6 months after the initial infarction
.
Female (%o)
Mean age (yr)
Previous myocardial infarction (%)
Anterior Q wave myocardial infarction (%)
Non-Q wave myocardial infarction
History (%)
Hypertension
Angina pectoris (>1 mo)
Diabetes mellitus
Mean time from onset of pain to study entry (h)
12,381
8,907 (85 .6%)
V
=(2.517v)
Medications and revascularization procedures during hos-
pital admission and follow-up . The cardiovascular treatment
regimen and the incidence of revascularization procedures are
reported in Table 2. At the time of hospital discharge, nearly
75% of patients were taking aspirin (altogether slightly >80%
were taking antiplatelet drugs), 25% were taking beta-
adrenergic blocking agents and nearly 33% were taking cal-
cium channel antagonists . The corresponding values at
6-month follow-up were somewhat lower for aspirin, slightly
lower for beta-blockers and higher for calcium antagonists .
Overall, these figures compared with the lower values observed
in the corresponding cohorts of the GISSI-1 trial indicate an
increase in the use of antiplatelet agents (82.4% vs. 47.1%, p <
0.001 at hospital discharge and 75 .5% vs. 45.2%, p < 0.001 at
6-month follow-up) and beta-blockers (25 .3% vs. 9.9%, p <
0.001 at hospital discharge and 24 .7% vs. 11 .3%, p < 0.001 at
Table 1. Baseline Characteristics of 8, 0
07 Patients in the GISSI-2
Data Base
18 .2
61 .0
13 .7
32.7
15 .6
35 .4
20.7
14.1
2.5
patients randomized with
complete data available for
analysis (911% of randomized)
10,407
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.289
hospital survivors with confirmed AMI
patients with complete follow-up
information concerning reinfarction status
nonfatal reinfarctions
6-month follow-up). Patients who underwent percutaneous
transluminal coronary angioplasty or coronary artery bypass
surgery after the index event comprised only No of the study
group. As expected, higher incidence rates of revascularization
procedures were seen in patients with residual ischemia .
Cumulative rates of 19 .4% and 14 .5%, respectively, were
observed among patients with early postinfarction angina
(in-hospital rates 2 .1% for coronary angioplasty and 1 .5% for
coronary bypass surgery ; postdischarge rates by 6 months 4 .0%
for angioplasty and 11 .8% for bypass surgery) and with a
Table 2 . Medications and Revascularization Procedures at Hospital
Discharge and at 6-Month Follow-Up of 8,907 Hospital Survivors
hospital survivors
*Incidence rates observed after hospital discharge
.
At Discharge
At 6 Months
Medication
Beta-blocking agents 25 .3
24 .7
Antiarrhythmic agents
10 .4 10 .0
Calcium channel antagonists
35 .5
41 .3
Digitalis
8 .6 10.7
Diuretic drugs
18 .8 18 .9
Angiotensin-converting enzyme inhibitors
1011 13 .3
Antiplatelet agents
Aspirin
76 .7
63.8
Other
5 .7 13 .7
Revascularization procedure
Coronary angioplasty
0.6
1 .9 1
Coronary bypass surgery
0.4
4 .1
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positive exercise test (in-hospital rates 1 .1% for angioplasty
and 0.8% for bypass surgery; postdischarge rates by 6 months
4.5% for angioplasty and 8 .1% for bypass surgery).
Univariate analysis. Of the 16 selected variables, only 5
were univariately predictive of recurrent nonfatal myocardial
infarction, that is exclusion from exercise testing for cardiac
reasons (odds ratio 4 .74, 95% confidence interval [CI] 2 .99 to
7.53), a history of previous myocardial infarction (odds ratio
2.71, 95% CI 1 .84 to 4.0)), angina at follow-up (odds ratio 2 .11,
95% CI 1 .48 to 3.00), history of angina (odds ratio 1 .81, 95%
CI 1 .30 to 2 .52) and history of treated hypertension (odds ratio
1.38, 95% CI 1 .02 to 1 .86).
Of 1,500 patients with postdischarge angina, 41% were
classified as having effort angina, 33% as having spontaneous
angina and 22% as having mixed angina . For 55 patients (4%)
detailed classification was missing. A nonsignificant trend
toward a greater incidence of nonfatal reinfarction was ob-
served in patients with mixed or spontaneous angina than in
those with effort angina (4.8% vs. 2.9%, p = NS) .
Multivariate analysis. On multivariate analysis, performed
according to the Cox model (17), three variables were retained
as independent predictors of nonfatal reinfarction : the exclu-
sion from the exercise test for cardiac reasons, previous
myocardial infarction and angina at follow-up (Table 3) . A
complex indicator such as the process of being excluded from
the exercise test for cardiac reasons turned out to be the most
potent risk predictor. Conversely, noncardiac ineligibility for
exercise test was not a predictive factor . A trend toward an
increased risk of nonfatal reinfarction was observed for a
history of angina (relative risk 1.30, 95% CI 0 .96 to 1 .75) .
Notably, indicators of residual myocardial ischemia, such as
early postinfarction angina and a positive exercise test, did not
appear to be risk determinants. A similar conclusion applies to
other variables (demographic [age >70 years, female gender],
historical [history of treated hypertension, history of diabetes
mellitus and history of cigarette smoking] and ECG [inferior
location of infarct and presence of complex ventricular ar-
rhythmias on H.:ilter monitoring]) as well as to indicators of the
extent of myocardial damage after infarction (early and late
left ventricular failure, recovery phase left ventricular dysfunc-
tion).
Fu tber analysis in patients with echocardiographic and
24-h Hotter monitoring data available. To further investigate
factors actually associated with increased risk of nonfatal
reinfarction a separate multivariate analysis was performed oa
JACC Vol. 24, No . 3
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'A negative exercise test was the reference category. CI = confidence
interval .
the subgroup of 6,580 patients with both echocardiographic
and Holler monitoring data available, in which 154 recurrences
were observed (2.3% incidence rate) .
Univariate analysis. In this subgroup the same factors as in
the previous analysis were risk predictors with the sole excep-
tion of a history of treated hypertension. With respect to
eligibility for exercise testing, significant (p < 0.01) imbalances
in all the selected variables were observed between patients
who were excluded from exercise testing for cardiac reasons
and those who were tested . Indeed, the excluded patients not
only had a greater prevalence of female gender and advanced
age but also had a more complicated previous history and
clinical course after the index infarction . This more serious risk
profile was also evidenced by the greater prevalence among
these patients of digitalis, diuretic and antiarrhythmic therapy,
as well as the lesser frequency of beta-blocker therapy, at
hospital discharge .
Multivariate analysis On multivariate analysis the three
factors (cardiac ineligibility for exercise testing, previous in-
farction and postdischarge angina) that were originally found
to be significantly correlated with nonfatal reinfarction were
still retained as independent risk indicators (Table 4). In
addition, a history of angina emerged as a risk prdictor,
ranking third behind ineligibility (cardiac) for exercise stress
testing and a history of previous infarction . Conversely, early
postinfarction angina and a positive exercise test were not
related to recurrent nonfatal infarction .
Low risk patients. Factors predictive of outcome allowed
the identification of a subset of patients (2,915 [33%] of 8,907)
with a 4.3% 6-month rate of nonfatal reinfarction (124 events
[56% of the total]), whereas a 1 .6% recurrence rate was
observed among patients without any risk factor . However,
44% of the overall number of events occurred in this low risk
group. Moreover, aside from an empiric variable such as
cardiac ineligibility for exercise testing, 54% of events occurred
in this group. Roughly similar estimates were seen in the
subgroup of 6,580 patients with echocardiographic and Holter
ECG monitoring data available. In this latter subgroup, pa-
tients with two of four predictors of nonfatal reinfarction
(10.5% of the total) had a 5.8% recurrence rate. However, in
this 690 patient subset, only 40 (26%) of 154 end point events
were observed.
Recurrent nonfatal or fatal infarction as end point. When
the end point was taken to be any recurrent myocardial
Table 3. Ranked Independent Predictors of Nonfatal Reinfarction
Among 8,907 Hospital Survivors (Cox model)
Table 4. Ranked Independent Predictors of Nonfatal Reinfarction
Among 6,580 Hospital Survivors With Echocardiographic and
Holter Monitoring Data Available (Cox model)
Relative
Variable Risk
95% Cl
Relative
Ineligibility (cardiac) for exercise test' 2 .97 1
.98-4.45
Risk 95% Cl
Previous myocardial infarction 1 .70 1 .22-2.36
Ineligibility (cardiac) for exercise test' 2.32 1 .41-3 .82
Angina at follow-up 1 .50 1 .10-2.04
Previous myocardial infarction 1 .78 1 .20-2 .64
History of angina 1 .58 1 .10-2 .25
'A negative exercise test was the reference category. CI = confidence
Angina at follow-up 1 .47 1 .01-2 .15
interval .
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infarction (nonfatal or clinically reported fatal recurrences),
the conclusions of this study were quite similar .
INSCUSSI)n
Rate of recurrent nonfatal myocardial infarction. An -5%
to 10% incidence rate of recurrent nonfatal infarction in the
year after hospital discharge has been reported (1,2,8,18-20)
in survivors of myocardial infarction . The lower estimate of
this range implies a 6-month rate slightly >3% (8), a figure
that appears comparable to the relatively low rate of 2 .5%
observed Lt the present study. This GISSI-2 reinfarction rate,
midway between the percentages found in the corresponding
cohorts of the GISSI4 trial, most like!y represents the net
result of two contrasting factors: 1) a recent history of early
thrombolytic treatment with its attendant higher risk of rein-
farction (21), and 2) increasing use of beta-blockers and
antiplatelcl agents (22,23) . A case can be made that this low
nonfatal reinfarction rate has been influenced to some extent
by exclusion from the analysis of a subset of patients without
information on reinfaTction, who exhibited a poorer survival
rate and thus were likely to be at a higher risk of reinfarction .
Another explanation for the observed low event rate might
relate to the lower incidence of multivessel disease seen among
patients included in thrumbolytic trials in comparison with
historical control subjects (24) .
Predictors of recurrent nonfatal infarction . In the past
there have been difficulties in developing models for predicting
recurrent myocardial infarction (4,5) . Even in more recent
major studies (1,6-8,25,26), involving >400 patients, discrep-
ancies and inconsistencies are apparent, with only a few
variables (i .e., history of previous angina or diabetes and
continued cigarette smoking) identified as independent risk
factors for recurrent infarction in at least two investigations
(27) . Thus, the results of the present study should be discussed
in the light of this background information .
En the GISSI-2 patients studied here, cardiac ineligibility for
exercise testing emerged as the most powerful predictor of
nonfatal reinfatction . This finding parallels the already re-
ported strong association with all-cause mortality (9) and
reinforces the concept that cardiac ineligibility for exercise
testing identifies a high risk group of postinfarction patients
(1,16,18) .
In keeping with the results of a major data base study (8),
two variables reflecting a history of coronary artery disease
before the index infarction were independent predictors of
nonfatal reinfarction (Tables 3 and 4). This observation might
reflect the reported greater likelihood of multivessel coronary
artery disease or more severe residual stenosis of the infarct-
related artery after thrombolytic therapy, or both, among
patients with a history of either previous infarction or previous
angina (28,29). However, in addition to the role played by the
extent of coronary disease and the severity of residual stenosis,
more specifically these findings appear to indicate a greater
incidence in these patients of active coronary lesions with a
particular propensity to generate unstable plaques and thereby
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trigger new coronary events (30). On the basis of these
findings, broader indications for coronary angiography and a
lower threshold for recommending angioplasty or bypass sur-
gery appear appropriate in patients with a history of previous
infarction or angina pectoris preceding the index infarction,
especially in the presence of other markers of risk (9,29131).
The occurrence of angina pectoris after hospital discharge
was of prognostic value with respect to a nonfatal reinfarction .
This finding is in line with those of one other large study,
although the association found in the present study does not
appear as strong as previously indicated (8). Moreover, caution
is needed in interpreting the clinical relevance of these data
because angina at follow-up, representing true prodromal
syndrome and thus in close pathogenetic linkage with the
cascade of events ultimately leading to the new infarction,
could not be reliably identified and excluded from the analysis .
Variables not predictive of recurrences. Qualitative mark-
ers of residual ischeinia, such as early postinfarction angina
and a positive exercise test (i .e ., effort ischemia), were not
predictors of the prognostic end point . These findings, which
are consistent with those previously reported concerning all-
cause mortality (9), might have been influenced by the greater
incidence rates of revascularization procedures observed in
patients with residual ischemia. However, additional factors
must be taken into account to explain these data. Previous
studies (1,8) examining recurrent infarction as a separate end
point have reached conflicting conclusions as to the predictive
role of early postinfarction angina. This disagreement most
likely reflects the variability in the characteristics of the
patients studied and suggests that the clinical entity of early
postinfarction angina includes various patient subsets at widely
different levels of risk for recurrent coronary events . Should
this assumption be correct, it would be all the more important
in future investigations to search for harbingers of reinfarction
relying on new (and perhaps semiquantitative) indicators of
recurrent ischemia instead of a simple clinical and ECG
variable such as early postinfarction angina .
That effort ischemia was not of prognostic value may also be
explained by the observed low event rate, a factor known to
lower the positive predictive value of an abnormal stress test .
This inability of a positive exercise test to predict nonfatal
reinfarction is consistent with the majority of available studies
(1,7,25,26,32-37). It is also not surprising because an important
proportion of myocardial infarctions are known to be caused
by the sudden development of severe coronary obstruction or
occlusion from preexisting mildly stenotic atherosclerotic
plaques, rather than gradual progression of severe arterial
narrowings, whose ischemic potential can be exposed by non-
invasive evaluation (24,38,39). Moreover, even the correlation
between angiographic severity of the residual coronary artery
stenosis after thrombolysis or other morphologic characteris-
tics and the risk of subsequent reinfarction has been ques-
tioned (26,40,41). Nonetheless, the findings of this study do not
exclude the possibility that an indicator of severe exercise-
induced ischemia may predict an increased risk of nonfatal
Teinfarcfion (42) .
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The lack of an association between some historical variables
reflecting conventional risk
factors for myocardial infarction
(i .e., history of treated hypertension, insulin-dependent diabe-
tes and history of cigarette smoking) and nonfatal recurrences
of infarction may be explained by the relatively short follow-up
period of this study. It is worth recalling that similar findings
were reported by some but not all previous studies (1,6-
8,26,43-45) of recurrent infarction in which either nonfatal
reinfarction alone or a fatal plus nonfatal recurrence was taken
to be the end point. It must be also underscored that the
variable used in this data base to examine cigarette smoking
relates to smoking status evaluated only at hospital admission
and, in contrast to other studies (6,26), no subsequent infor-
mation was obtained .
Not surprisingly (27), indicators of left ventricular dysfunc-
tion as well as demographic (age and gender) and FCC :
variables (infarct site and complex ventricular arrhythmias on
Hotter monitoring) were not of prognostic relevance . Data
concerning infarct type confirm the results of other major
investigations (3,8,46 .4!) .
St limitations. The results of the present study relate to
a group of low risk postinfarction patients (2 .1% death rate at
6 months). Thus, they may not apply to different patient groups
with higher event rates or higher rates of revascularization
procedures.
Coudusions . Overall, accumulating evidence from this and
other studies carried out before and after the advent of
thrombolytic therapy (1,7,8,25) indicates that risk factors for
recurrent nonfatal infarction arc different from those known to
be related to reduced survival. Moreover, the observation that
in this data base study almost one in two such reinfarctions
occurred in patients without any of the identified risk factors
confirms that also among patients who have received throm-
bt lyttic therapy, prediction t)f nonfatal reinfarction is even less
accurate than prediction of fatal outcome (8). This disappoint-
ing realization, further reinforced by the negative or at best
contradictory findings of studies examining the predictive value
of angiographic variables (7,25,26,40.41), underlines the limi-
tations of present knowledge of factors that promote and
determine the initpation and timing of coronary thrombosis
and acute myocardial infarction (49,50) . It is hoped that the
prospective assessment of new biologic markers of risk (51-55)
in future studies may make the prediction of recurrent nonfatal
infarction a more fruitful endeavor.
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